DURECT

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DURECT and buy or sell other stocks, ETFs, and their options commission-free!

About DRRX

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. 

CEO
James E. Brown
CEOJames E. Brown
Employees
31
Employees31
Headquarters
Cupertino, California
HeadquartersCupertino, California
Founded
1998
Founded1998
Employees
31
Employees31

DRRX Key Statistics

Market cap
23.18M
Market cap23.18M
Price-Earnings ratio
-4.09
Price-Earnings ratio-4.09
Dividend yield
—
Dividend yield—
Average volume
778.67K
Average volume778.67K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$2.61
52 Week high$2.61
52 Week low
$0.492
52 Week low$0.492

People also own

Based on the portfolios of people who own DRRX. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Zomedica
Ideanomics
Castor Maritime
Northern Dynasty Minerals
TherapeuticsMD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.